The first detectable pathology of AD in the cerebrospinal fluid (CSF) is reduced concentration of amyloid-β 42 (Aβ42), followed by an increase in phosphorylated tau (P-tau) and total-tau (T-tau; Palmqvist et al., 2019). The gene discussed is MAPT; the disease is Alzheimer disease.